Kumar refers to the early retatrutide data as remarkable from a clinical perspective
The number of serious issues that occurred, like cancer or infection, was slightly lower in the semaglutide group
What If Medication Was Left Out
The company had 67,700 employees at the end of 2025, 88% of whom were based in the U.S
GLP-1s are not recommended for people with medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease
Costs and Insurance Coverage The cost of these weight-loss medications can vary widely depending on insurance coverage and specific program options: By means of an access program, Contrave proposes to receive the medicine for $99 monthly through a mail-order pharmacy without evidence of insurance position